Riskpilot← Back to searchSign inGet full accessMedicineGarden AB
ABActiveOrg 5568875180Skeppsbron 5Wholesale of other food · NACE 4638Est. 20123 employees
Revenue 2024
SEK 47M
+27% vs 2023
EBITDA margin
6.1%
+809% vs 2023
Equity ratio
21.7%
Financial strength
Net profit 2024
SEK 2,8M
+4519% vs 2023
| Revenue | SEK 47M | +27% |
| EBITDA | SEK 2,9M | +809% |
| Net profit | SEK 2,8M | +4519% |
| Total assets | SEK 13,6M | +31% |
| Equity | SEK 2,9M | +1583% |
| Employees | 3 | — |
Legal name
MedicineGarden AB
Org number
5568875180
Legal form
Aktiebolag
NACE code
4638 · Wholesale of other food
Founded
13 mars 2012
Share capital
SEK 50 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva import och handel med hälsoprodukter samt konsultverksamhet inom PR och marknadsföring och därmed förenlig verksamhet.
Address
Skeppsbron 5
Phone
+46705949195
Email
tom@medicinegarden.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 27 974 | 32 148 | 35 375 | 37 059 | 47 005 |
| Staff expenses | — | — | — | — | −1 344 |
| EBITDA | 242 | −418 | −5 570 | 317 | 2 881 |
| Depreciation & amort. | −35 | −41 | −55 | −55 | −55 |
| EBIT | 207 | −459 | −5 625 | 262 | 2 826 |
| Net financials | −1 | −2 | −69 | −203 | −54 |
| Profit before tax | 206 | −461 | −5 694 | 60 | 2 772 |
| Tax | −0 | −0 | −0 | −0 | — |
| Net profit | 206 | −461 | −5 694 | 60 | 2 772 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 12 049 | 13 920 | 18 634 | 10 341 | 13 586 |
| Equity | 1 270 | 809 | −4 085 | 175 | 2 946 |
| Long-term debt | 350 | 300 | 1 078 | 798 | 414 |
| Short-term debt | 10 428 | 12 811 | 21 641 | 9 368 | 10 227 |
| Total debt | 10 778 | 13 111 | 22 719 | 10 166 | 10 640 |
EBITDA margin
6.1%
This company
15.8%
Market median
-61% vs market
20202024
Equity ratio
21.7%
This company
38.2%
Market median
-43% vs market
20202024
Return on equity
94.1%
This company
18.4%
Market median
+411% vs market
20202024
Net profit margin
5.9%
This company
8.1%
Market median
-27% vs market
20202024
Asset turnover
3.46×
This company
1.12×
Market median
+209% vs market
20202024
Debt / equity
3.61×
This company
0.62×
Market median
-482% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MA | Audit | 2022 |
TE Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MedicineGarden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats Anders Gyllenberg | Audit | 0 companies |
| Tom Eric Anders Johnsson | Chief Executive Officer | 0 companies |
| Maibritt Johnsson | Deputy Board Member | 0 companies |